Integrated Cloud And Digital Health Solutions Will Create Enduring Opportunity

Key Takeaways

• Transition to integrated, cloud-based platforms is driving increased customer retention and a greater share of high-margin, recurring software revenue.
  
• Healthcare digitalization and demographic trends are fueling sustained demand, while operational improvements are supporting further margin and earnings growth.
  
• Persistent macroeconomic, currency, migration, and regulatory challenges threaten revenue, margins, and competitive positioning amid intensifying industry rivalry and evolving client requirements.

Catalysts

Provides healthcare ICT and mobile workflow solutions worldwide.

• The shift to cloud-enabled, integrated platform solutions is expected to increase customer stickiness and expand Ascom's ability to cross-sell services, directly supporting recurring revenue growth and improving gross margins as more solutions move to higher-margin software-based offerings.
  
• The combination of an aging global population and the accelerating digitalization of healthcare workflows continues to drive long-term demand for real-time communication and workflow optimization, underpinning mid
• to long-term revenue growth despite current market volatility.
  
• A visible improvement in operational efficiency, cost discipline, and a streamlined organizational structure is enhancing EBITDA progression and should continue to support margin expansion and earnings growth as short-term restructuring costs subside.
  
• Recent customer wins, strategic partnerships, and the expansion of platform rollouts across regions indicate growing market penetration, which is likely to positively impact future order intake and top-line revenue as delayed investments and project backlogs normalize.
  
• Successful migration of existing customers to next-generation platforms-and the addition of advanced features such as pre-emptive alarming and smart alarm filtering-position Ascom to capture a larger share of digital transformation investment, supporting both revenue acceleration and a shift to higher-margin, recurring software revenues.

Ascom Holding Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Ascom Holding's revenue will grow by 2.4% annually over the next 3 years.
• Analysts assume that profit margins will increase from 5.2% today to 5.5% in 3 years time.
• Analysts expect earnings to reach CHF 17.3 million (and earnings per share of CHF 0.49) by about May 2029, up from CHF 15.1 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.5x on those 2029 earnings, up from 13.5x today. This future PE is greater than the current PE for the GB Healthcare Services industry at 13.5x.
• Analysts expect the number of shares outstanding to decline by 6.83% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 4.76%, as per the Simply Wall St company report.

Risks

• Prolonged market volatility and macroeconomic uncertainties, especially in the U.S. & Canada, have led to investment delays and a decline in order intake, potentially dampening revenue growth over the long term if such trends persist.
  
• Continued adverse currency fluctuations, with key currencies like the U.S. dollar, euro, and Nordic currencies weakening against the Swiss franc, have already reduced net revenue and could continue to negatively impact reported financials and earnings.
  
• Despite efforts to transition to cloud-enabled, integrated platforms, Ascom faces risk from delays and incremental migration for both existing and new customers, which could slow revenue acceleration and burden margins if upgrade incentives or migration costs outstrip realized efficiencies in the early stages.
  
• The company remains exposed to competition from larger players and innovative startups in digital health, particularly as the industry trend favors fully integrated, single-vendor solutions, potentially leading to pricing pressure, margin compression, and loss of market share.
  
• Ongoing regulatory, trade, and tariff uncertainties (such as U.S.–China tariffs and evolving healthcare standards) create increased risk of compliance costs, supply chain disruption, and margin erosion, which may offset cost-cutting gains and undermine long-term earnings stability.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of CHF7.9 for Ascom Holding based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CHF10.2, and the most bearish reporting a price target of just CHF5.6.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be CHF313.6 million, earnings will come to CHF17.3 million, and it would be trading on a PE ratio of 14.5x, assuming you use a discount rate of 4.8%.
• Given the current share price of CHF5.98, the analyst price target of CHF7.9 is 24.3% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.